German chemicals giant Bayer yesterday said it had increased its earnings and profits forecasts after signing a deal to take over US seeds and pesticides maker Monsanto.
“We are optimistic for the medium-term development of Bayer and have set ourselves correspondingly ambitious targets,” chief executive Werner Baumann said in a statement.
In the crop science division that would integrate Monsanto, Bayer said it would grow sales faster than the market and increase its profit margin to “more than 30 percent” after 2020, three years after the merger is slated to be finalized.
Between them, Monsanto and Bayer’s crops division brought in 23.1 billion euros (US$25.8 billion) in sales last year.
Bayer justified the predictions with a “broad product palette and research and development pipeline” for the two companies, adding that the merged firms would bring new products to market faster.
The 58.8-billion-euro deal is the largest takeover in history for a German firm and would create a giant in the agribusiness sector.
However, the tie-up still has to be voted through by Monsanto shareholders and pass regulators’ scrutiny in both Europe and the US.
Environmental groups on both sides of the Atlantic have promised fierce opposition to the deal.
Baumann said the pharmaceuticals division, one of two other major business areas, looked forward to “particularly high growth in sales and margins”.
The prescription medicines unit would target annual sales growth of 6 percent on average until the end of 2018, the firm said, and boost margins to “between 32 and 34 percent” compared with last year’s 30 percent.
Bayer pointed to a stable of five new medications — forecast to bring in 10 billion euros in annual sales, up from 7.5 billion — and a “highly promising” pipeline in the division to explain its optimism.
“By the end of 2023, we are planning to launch at least 20 new products in pharmaceuticals,” Baumann said.
Meanwhile, the consumer health unit aims to increase sales and margins by focusing on its globally-recognized brands, such as Aspirin, and key markets, including the US, Russia, China and Brazil.
Bayer added that the group would “exhaust the potential for licensing previously prescription-only medications for self-medication” as well as developing new digital health offerings.
purpose: Tesla’s CEO sought to meet senior Chinese officials to discuss the rollout of its ‘full self-driving’ software in China and approval to transfer data they had collected Tesla Inc CEO Elon Musk arrived in Beijing yesterday on an unannounced visit, where he is expected to meet senior officials to discuss the rollout of "full self-driving" (FSD) software and permission to transfer data overseas, according to a person with knowledge of the matter. Chinese state media reported that he met Premier Li Qiang (李強) in Beijing, during which Li told Musk that Tesla's development in China could be regarded as a successful example of US-China economic and trade cooperation. Musk confirmed his meeting with the premier yesterday with a post on social media platform X. "Honored to meet with Premier Li
Dutch brewing company Heineken NV on Friday announced an investment of NT$13.5 billion (US$414.62 million) over the next five years in Taiwan. The first multinational brewing company to operate in Taiwan, Heineken made the statement at a ceremony held at its brewery in Pingtung County. It also outlined its efforts to make the brewery “net zero” by 2030. Heineken has been in the Taiwanese market for 20 years, Heineken Taiwan managing director Jeff Wu (吳建甫) said. With strong support from local consumers, the Dutch brewery decided to transition from sales to manufacturing in the country, Wu said. Heineken assumed majority ownership and management rights
ARTIFICIAL INTELLIGENCE: The chipmaker last month raised its capital spending by 28 percent for this year to NT$32 billion from a previous estimate of NT$25 billion Contract chipmaker Powerchip Semiconductor Manufacturing Corp (力積電子) yesterday launched a new 12-inch fab, tapping into advanced chip-on-wafer-on-substrate (CoWoS) packaging technology to support rising demand for artificial intelligence (AI) devices. Powerchip is to offer interposers, one of three parts in CoWoS packaging technology, with shipments scheduled for the second half of this year, Powerchip chairman Frank Huang (黃崇仁) told reporters on the sidelines of a fab inauguration ceremony in the Tongluo Science Park (銅鑼科學園區) in Miaoli County yesterday. “We are working with customers to supply CoWoS-related business, utilizing part of this new fab’s capacity,” Huang said, adding that Powerchip intended to bridge
Microsoft Corp yesterday said that it would create Thailand’s first data center region to boost cloud and artificial intelligence (AI) infrastructure, promising AI training to more than 100,000 people to develop tech. Bangkok is a key economic player in Southeast Asia, but it has lagged behind Indonesia and Singapore when it comes to the tech industry. Thailand has an “incredible opportunity to build a digital-first, AI-powered future,” Microsoft chairman and chief executive officer Satya Nadella said at an event in Bangkok. Data center regions are physical locations that store computing infrastructure, allowing secure and reliable access to cloud platforms. The global embrace of AI